References
- Burnet, F. M. (1970) The concept of immunological surveillance. Prog. Exp. Tumor Res. 13: 1-27
- Gough, M. J., Melcher, A. A., Ahmed, A., Crittenden, M. R., Riddle, D. S., Linardakis, E., Ruchatz, A. N., Emiliusen, L. M. and Vile, R. G. (2001) Macrophages orchestrate the immune response to tumor cell death. Cancer Res. 61: 7240-7247
- Schnurr, M., Scholz, C., Rothenfusser, S., Galambos, P., Dauer, M., Robe, J., Endres, S. and Eigler, A. (2002) Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. Cancer Res. 62: 2347-2352
- Strome, S. E., Voss, S., Wilcox, R., Wakefield, T. L., Tamada, K., Flies, D., Chapoval, A., Lu, J., Kasperbauer, J. L., Padley, D., Vile, R., Gastineau, D., Wettstein, P. and Chen, L. (2002) Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 62: 1884-1889
- Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S. and Zitvogel, L. (2001) Tumorderived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7: 297-303 https://doi.org/10.1038/85438
- Rosenberg, S. A., Yang, J. C. and Restifo, N. P. (2004) Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915 https://doi.org/10.1038/nm1100
- Berzofsky, J. A., Terabe, M., Oh, S., Belyakov, I. M., Ahlers, J. D., Janik, J. E. and Morris, J. C. (2004) Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J. Clin. Invest. 113: 1515-1525 https://doi.org/10.1172/JCI21926
- Chaput, N., Schartz, N. E., Andre, F., Taieb, J., Novault, S., Bonnaventure, P., Aubert, N., Bernard, J., Lemonnier, F., Merad, M., Adema, G., Adams, M., Ferrantini, M., Carpentier, A. F., Escudier, B., Tursz, T., Angevin, E. and Zitvogel, L. (2004) Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 172: 2137-2146 https://doi.org/10.4049/jimmunol.172.4.2137
- Miconnet, I., Koenig, S., Speiser, D., Krieg, A., Guillaume, P., Cerottini, J. C. and Romero, P. (2002) CpG are efficient adjuvants for specific CTL induction against tumor antigenderived peptide. J. Immunol. 168: 1212-1218 https://doi.org/10.4049/jimmunol.168.3.1212
- Azuma, I. (1992) Synthetic immunoadjuvants: application to non-specific host stimulation and potentiation of vaccine immunogenicity. Vaccine 10: 1000-1006 https://doi.org/10.1016/0264-410X(92)90108-V
- Audibert, F. M. and Lise, L. D. (1993) Adjuvants: current status, clinical perspectives and future prospects. Immunol. Today 14: 281-284 https://doi.org/10.1016/0167-5699(93)90046-N
- Gupta, R. K. and Siber, G. R. (1995) Adjuvant for human vaccines-current status, problems and future prospects. Vaccine 13: 1263-1376 https://doi.org/10.1016/0264-410X(95)00011-O
- Bennet, B., Check, I. J., Olsen, M. R. and Hunter, P. L. (1992) A comparison of commercially available adjuvants for use in research. J. Immunol. Method 153: 31-40 https://doi.org/10.1016/0022-1759(92)90302-A
- Tamura, M., Yoo, Y. C., Yoshimatsu, K., Yoshida, R., Oka, T., Ohkuma, K., Arikawa, J. and Azuma, I. (1995) Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen. Vaccine. 13: 77-82 https://doi.org/10.1016/0264-410X(95)80015-6
- Rickman, L. S., Gordon, D. M., Wistar, R. Jr., Krzych, U., Gross, M., Hollingdale, M. R., Egan, J. E., Chulay, J. D. and Hoffman, S. L. (1991) Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet 337: 998-1001 https://doi.org/10.1016/0140-6736(91)92659-P
- Kensil, C. R., Patel, U., Lennick, M. and Marciani, D. (1991) Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina Cortex. J. Immunol. 146: 431-437
- Gupta, R. K., Relyveld, E. H., Lindblad, E. B., Bizzini, B., Ben-Efraim, S. and Gupta, C. K. (1993) Adjuvants - a balance between toxicity and adjuvaticity. Vaccine 11: 293-306 https://doi.org/10.1016/0264-410X(93)90190-9
- Navarro-Garcia, F., Pedroso, M. and Lopez-Revilla, R. (2000) Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin. Clin. Immunol. 97: 182-188 https://doi.org/10.1006/clim.2000.4918
- Park, E. J., Nan, J. X., Zhao, Y. Z., Lee, S.H., Kim, Y. H., Nam, J. B., Lee, J. J. and Sohn DH. (2004) Water-soluble polysaccharide from Eleutherococcus senticosus stems attenuates fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. Basic Clin. Pharmacol. Toxicol. 94: 298-304 https://doi.org/10.1111/j.1742-7843.2004.pto940607.x
- Davydov, M. and Krikorian, A. D. (2000) Eleutherococcus senticosus Maxim. (Araliaceae) as an adaptogen: a closer look. J. Ethnopharmacol. 72: 345-393 https://doi.org/10.1016/S0378-8741(00)00181-1
- 윤택준, 이석원, 신광순, 최원희, 황수현, 서상희, 김성훈, 박우문 (2002) 가시오가피 열수추출물의 전신성 anaphylaxis에 대한 억제효과. 한국식품과학회지 34: 518-523
- Han, S. B., Yoon, Y. D., Ahn, H. J., Lee, H. S., Lee, C.W., Yoon, W. K., Park, S. K. and Kim, H.M. (2003) Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Int. Immunopharmacol. 3: 1301-1312 https://doi.org/10.1016/S1567-5769(03)00118-8
- Ha, E. S., Hwang, S. H., Shin, K. S., Yu, K. W., Lee, K. H., Choi, J. S., Park, W. M. and Yoon T. J. (2004) Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation. Arch. Pharm. Res. 27: 217-224 https://doi.org/10.1007/BF02980109
- 하은숙, 황수현, 유광원, 신광순, 조형민, 김창한, 박우문, 윤택준 (2003) 오가피로부터 분리된 조다당분획물의 면역 자극활성 및 cisplatin과의 병용투여에 의한 항암 상승작용 의 유도. 약학회지 47: 159-166
- 황수현, 하은숙, 유광원, 신광순, 이상훈, 이재권, 이경호, 윤택준, 박우문 (2003) 오가피 조다당의 단백질 항원(BSA and OVA)에 대한 면역증강효과. 약학회지 47: 167-175
- Sung, J. Y., Yoon, T.J., Yu, K.W., Lee, K.H. and Lee, H. (2006) Enhancement of immunological activities in mice by oral administration of pectic polysaccharides from Eleutherococcus senticosus. Food Science Biotech. 15: 117-121
- 윤택준, 이창권, 박태규, 이광호 (2005) 팔선초 물추출물의 면역자극 및 항종양 활성. 생약학회지 36: 332-337
- Ribas, A., Butterfield, L. H., Glaspy, J. A. and Economou, J. S. (2003) Current developments in cancer vaccines and cellular immunotherapy. J. Clin. Oncol. 21: 2415-2432 https://doi.org/10.1200/JCO.2003.06.041
- Fields, R. C., Shimizu, K. and Mule, J. J. (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 9482-9487
- Hill, H. C., Conway, T. F. Jr., Sabel, M. S., Jong, Y. S., Mathiowitz, E., Bankert, R. B. and Egilmez, N. K. (2002) Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Cancer Res. 62: 7254-7263